Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-008096
Filing Date
2021-04-06
Accepted
2021-04-06 16:05:59
Documents
2
Period of Report
2021-03-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 9680
2 ex24.htm EX-24 10591
  Complete submission text file 0001493152-21-008096.txt   21953
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCO SECURITIES LLC 1285 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK NY 10019
Business Address
Alvino Mark (Reporting) CIK: 0001356828 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 21809265